Phase 4 N=92 The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease
Alzheimer's Disease
Primary: Change From Baseline in Simple Reaction Time — -30.92; 180.83 seconds
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=105 Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma
Carcinoma, Renal Cell
Primary: Progression-free Survival (PFS) — 61.7 Weeks
Phase 4 N=215 Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Schizophrenia · Schizoaffective Disorder
Primary: Change in Non-HDL Cholesterol Level for Patients Assigned to Stay and Patients Assigned to Switch Over 24 Weeks — -20.2; -10.8 mg/dL non-HDL cholesterol
Phase 4 N=38 Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans
Effects of 2 Mu-opiates on Gastrointestinal Transit
Primary: Colonic Transit, Geometric Center at 24 Hours — 2.06; 2.07; 2.17 units on a scale
Phase 4 N=45 Intranasal Insulin Treatment in Patients With Schizophrenia
Schizophrenia
Primary: Cognitive Function- Digit Span Total — 13.3; 14.1 Items correct
Phase 4 N=3,031 Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
Hypertension · Ischemic Heart Disease · Congestive Heart Failure
Primary: New Onset or Recurrence of Stroke — 25; 46 event number — p=<0.05
Phase 4 N=110 The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
Coronary Artery Disease
Primary: Inhibition of Platelet Aggregation (IPA) in Prasugrel-treated and Clopidogrel-treated Smokers and Non-smokers Following 9 Days of Maintenance Therapy. — 70.3; 65.6…
Phase 4 N=611 Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
Diabetes · Diabetes Mellitus, Type 2
Primary: Change From Baseline in Body Weight — -1.05; -0.56 kg — p=0.132
Phase 4 N=3,029 Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients
GERD
Primary: Efficacy of Three Strategies of Long-term Treatment — 10.6; 7.8; 43 Percentage of participants with failure
Phase 4 N=186 Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease
Peripheral Arterial Disease
Primary: Intra-patient Accuracy (Percent Agreement), On-site Data — 77.1; 80.6 percentage of agreement
Phase 4 N=102 Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
Atrial Fibrillation · Pulmonary Embolism · Deep Vein Thrombosis
Primary: In Patients Receiving Warfarin, a Pharmacogenetic Algorithm Dose Was Compared to Clinician Dosing (mg/wk). — 46.9; 35.4 mg/wk — p=< 0.05
Phase 4 N=17 Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
Glaucoma
Primary: Pre-Treatment IOP (Intraocular Pressure) — 21.8 mm Hg
Phase 4 N=90 A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men
HPV Vaccine Acceptability
Primary: Change From Baseline to Post Intervention to Follow-up (up to 3 Months) After the Interventions the Number of Participants Who Have Taken the HPV Vaccine — 0; 0; 0; 0…
Phase 4 N=91 A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)
Rheumatoid Arthritis
Primary: Percentage of Participants Who Responded to ≥ 6 of 12 Anti-pneumococcal Antibody Serotypes — 70.8; 60.0 percentage of participants
Phase 4 N=306 Lansoprazole to Treat Children With Asthma
Asthma
Primary: Change in Juniper Asthma Control Score (ACS) — 1.1; 1.0 score — p=0.12